Low level of radon in groundwater and drinking water in The Netherlands The determination of radon in a number of groundwater and finished drinking water samples from the Dutch provinces Overijssel and Limburg show a low level of radon.
Step forward in the battle against pertussis Addition of an extra adjuvant (additive) to the current pertussis vaccines could enhance the effectivity of these vaccines.
European directors meeting IANPHI On 14 and 15 April the European directors of national public health institutes (NPHIs) are present in Bilthoven to share knowledge, discuss topical issues and identify areas where a joint approach
Higher incidence of obesity and high blood pressure in new adult generations Younger generations are more at risk of developing health problems due to obesity and high blood pressure than previous generations.
One-quarter of lowest educated obese Among people aged 25 and older who have completed primary education at most, one-quarter are obese (seriously overweight). Among university graduates this figure is 6 percent.
Preliminary assessment of dietary exposure to 3-MCPD in the Netherlands During the production of refined vegetable oils and fats, and especially palm oil, a process contaminant called 3-MCPD is formed.
Lab tests alone not conclusive for diagnosis of Lyme disease Lyme disease can cause a variety of complaints in patients. Laboratory tests for the disease can support medical practitioners in making a diagnosis but are not necessarily conclusive.
Jacob van Klaveren appointed as guest Professor at the Technical University of Denmark On 15 March 2016, Jacob van Klaveren was appointed as guest Professor in risk-benefit analyses at the Technical University of Denmark, DTU.
Citizen science network produces accurate maps of fine air particles Measurements by thousands of citizen scientists in the Netherlands using their smartphones and the iSPEX add-on are delivering accurate data on fine air particles in the atmosphere that add valuabl
Sustainability of EU regulatory system on medicinal products In safeguarding the quality, safety and efficacy of medicinal products, the present EU regulatory system has become a time consuming and highly regulated process.